Publication|Articles|April 18, 2025
- Pharmaceutical Executive: April 2025
- Volume 45
- Issue 3
Pharmaceutical Executive: April 2025 Interactive Digital Edition
View the Pharmaceutical Executive April 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
about 1 year ago
‘Earning’ Powerabout 1 year ago
Milan Kalawadia: Carving Out New Pathwaysabout 1 year ago
Bringing Biotech Innovation Across Bordersabout 1 year ago
Using AI to Predict Launch Successabout 1 year ago
Improving Your Earned Media Strategy: Tips and Insightsabout 1 year ago
The Future of DTC in Pharmaabout 1 year ago
Maintaining Supply Chain Resiliency, No Matter the Circumstancesabout 1 year ago
Translating ‘Digital-First’ to Commercial Successover 1 year ago
HEOR: From Proving Product Value to Proving Its Own WorthAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner
2
GSK Enters $10.6 Billion Agreement to Acquire Nuvalent Inc.
3
Pharma Funding Roundup: City Therapeutics Closes $99.5 Million Series B, Eloxx Pharmaceuticals Announces Pricing of $66 Million Public Offering
4
Right–to-Try Does Not Undermine Clinical Trials
5